Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Branch

Showing results (141-150 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1987
Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidneyF Goto, E K Jackson, A Ohnishi, et al.
Renal Physiology and Biochemistry|July 1, 1995
Nitric oxide does not contribute to sodium retention and peripheral vasodilation induced by partial portal vein ligation in ratsS Murakami, J F Bernardo, T D Jacob, et al.
Biochemical Pharmacology|May 1, 1981
Preservation of glucuronidation in carbon tetrachloride-induced acute liver injury in the ratP V Desmond, R James, S Schenker, et al.
Gut|September 1, 1971
Clinical evaluation of fibreoptic sigmoidoscopy employing the Olympus CF-SB colonoscopeP R Salmon, R A Branch, C Collins, et al.
Gut|July 1, 1979
Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver diseaseM Homeida, C J Roberts, M Halliwell, et al.
Pharmacogenetics|June 1, 1992
The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancerC M Fleming, A Kaisary, G R Wilkinson, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
In vivo modulation of CYP enzymes by quinidine and rifampinR A Branch, A Adedoyin, R F Frye, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dogG Deray, R Sabra, W A Herzer, et al.
Journal of Clinical Pharmacology|May 23, 1998
Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measureR F Frye, A Adedoyin, K Mauro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1984
Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humansA Küpfer, R Patwardhan, S Ward, et al.
Pageof 26

Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1987
Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidneyF Goto, E K Jackson, A Ohnishi, et al.
Renal Physiology and Biochemistry|July 1, 1995
Nitric oxide does not contribute to sodium retention and peripheral vasodilation induced by partial portal vein ligation in ratsS Murakami, J F Bernardo, T D Jacob, et al.
Biochemical Pharmacology|May 1, 1981
Preservation of glucuronidation in carbon tetrachloride-induced acute liver injury in the ratP V Desmond, R James, S Schenker, et al.
Gut|September 1, 1971
Clinical evaluation of fibreoptic sigmoidoscopy employing the Olympus CF-SB colonoscopeP R Salmon, R A Branch, C Collins, et al.
Gut|July 1, 1979
Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver diseaseM Homeida, C J Roberts, M Halliwell, et al.
Pharmacogenetics|June 1, 1992
The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancerC M Fleming, A Kaisary, G R Wilkinson, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
In vivo modulation of CYP enzymes by quinidine and rifampinR A Branch, A Adedoyin, R F Frye, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dogG Deray, R Sabra, W A Herzer, et al.
Journal of Clinical Pharmacology|May 23, 1998
Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measureR F Frye, A Adedoyin, K Mauro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1984
Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humansA Küpfer, R Patwardhan, S Ward, et al.
Pageof 26